FDA Alters Levitra, Effexor XR Labels
This article was originally published in The Pink Sheet Daily
Executive Summary
Erectile-dysfunction package insert will now note phenomenon of sudden temporary memory loss.
You may also be interested in...
FDA Clears Wyeth’s Pristiq For Depression
New study in menopausal hot flashes and night sweats is due first half of this year.
ED Drug Labeling Revised For Potential Risk Of Hearing Loss
FDA identifies 29 postmarketing reports of sudden hearing loss in patients using PDE 5 inhibitors, including Cialis, Levitra and Viagra.
Rare Disease Roundtable: Dealing With Pricing Pressure
Part 2: High costs are built into the rare disease business model. Participants at a roundtable discussion led by Scrip at the J.P. Morgan Healthcare Conference talked about how much they are feeling the pressure on pricing.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: